Literature DB >> 18375642

Bromism caused by mix-formulated analgesic injectables.

P F Hsieh1, Y T Tsan, D Z Hung, C L Hsu, Y C Lee, M H Chang.   

Abstract

Bromism, chronic bromide intoxication, can be caused by a variety of medicines, but bromism due to pain-relieving injectable medications has not been reported. In this study, the methods used were internet searching on bromide-containing injectables available in Taiwan and the first case report of bromism due to mixed-formulated injectable medication. Many analgesic/antipyretic and antihistamine injections containing bromides are still being used in Taiwan. They contain sodium bromide up to 1000 mg/ampoule or calcium bromide up to 800 mg/amp. A 25-year-old female suffered from forgetfulness and unstable gait after long-term frequent injections of a preparation to relieve head and neck pain. Blood tests showed hyperchloremia (171 mEq/L) and a negative anion gap (-48.7 mEq/L). Serum bromide measured 2150 mg/L. She recovered completely in 3 days with saline treatment. Many bromide-containing injections are still being used in Taiwan. Clinicians should keep alert on this issue to avoid iatrogenic bromism or making misdiagnoses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18375642     DOI: 10.1177/0960327107087797

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  4 in total

1.  Case files of the medical toxicology fellowship at the New York City poison control: bromism: forgotten, but not gone.

Authors:  Daniel Lugassy; Lewis Nelson
Journal:  J Med Toxicol       Date:  2009-09

2.  Elevated serum levels of bromine do not always indicate pseudohyperchloremia.

Authors:  Takayasu Ito; Eiji Ishikawa; Yoshikazu Matsuda; Akiko Tanoue; Mika Fujimoto; Hiroshi Matsuo; Tomohiro Murata; Takuya Hiramoto; Masaaki Ito; Shinsuke Nomura
Journal:  Clin Exp Nephrol       Date:  2010-08-12       Impact factor: 2.801

3.  Ten Years of Robotripping: Evidence of Tolerance to Dextromethorphan Hydrobromide in a Long-Term User.

Authors:  Travis D Olives; Sean P Boley; Jenna M LeRoy; Samuel J Stellpflug
Journal:  J Med Toxicol       Date:  2019-03-22

4.  Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.

Authors:  Adrienne Tin; Girish Nadkarni; Anne M Evans; Cheryl A Winkler; Erwin Bottinger; Casey M Rebholz; Mark J Sarnak; Lesley A Inker; Andrew S Levey; Michael S Lipkowitz; Lawrence J Appel; Dan E Arking; Josef Coresh; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2018-05-18       Impact factor: 10.121

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.